H2RCY2 (H2RCY2_PANTR) Pan troglodytes (Chimpanzee)
Mitogen-activated protein kinase kinase kinase 7 UniProtKBInterProSTRINGInteractive Modelling
606 aa; Sequence (Fasta) ;
20 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
23 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of human TAK1 kinase domain fused with TAB1 | monomer | |||||
| Assess | ||||||
| Structural Basis for the Interaction of TAK1 Kinase with its Activating Protein TAB1 | monomer | 1×ADN; | ||||
| Assess | ||||||
| Structure of TAK1 in complex with compound 54 | monomer | 3×GOL; 1×DMS; 1×URW; | ||||
| Assess | ||||||
| Structure of TAK1 in complex with compound 22 | monomer | 5×GOL; 2×DMS; 1×UWZ; | ||||
| Assess | ||||||
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 11c | monomer | 1×6KC; | ||||
| Assess | ||||||
| Crystal structure of Takinib bound to TAK1 | monomer | 1×EDH; | ||||
| Assess | ||||||
| Crystal structure of TL10-81 bound to TAK1-TAB1 | monomer | 1×5KW; | ||||
| Assess | ||||||
| Irreversible Inhibition of TAK1 Kinase by 5Z-7-Oxozeaenol | monomer | 10×EDO; 1×1FM; | ||||
| Assess | ||||||
| Crystal structure of TL10-92 bound to TAK1-TAB1 | monomer | 1×T92; | ||||
| Assess | ||||||
| Crystal structure of SM1-71 bound to TAK1-TAB1 | monomer | 1×6H3; | ||||
| Assess | ||||||
| Crystal structure of TL11-128 bound to TAK1-TAB1 | monomer | 1×6L4; | ||||
| Assess | ||||||
| Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1 | monomer | 1×NG2; | ||||
| Assess | ||||||
| Crystal structure of TL11-113 bound to TAK1-TAB1 | monomer | 1×6H4; | ||||
| Assess | ||||||
| Crystal structure of compound 8 bound to TAK1-TAB | monomer | 1×YIY; | ||||
| Assess | ||||||
| Crystal Structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)furo[2,3-c]pyridin-4-yl]-1H-pyr… | monomer | 1×1UL; | ||||
| Assess | ||||||
| Crystal Structure of (1R,4R)-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)-3-chlorofuro[2,3-c]pyridi… | monomer | 1×1UO; 2×EDO; | ||||
| Assess | ||||||
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 4 | monomer | 1×6V5; | ||||
| Assess | ||||||
| Crystal Structure of 2-(1-benzothiophen-7-yl)-4-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]furo[2,3-c]pyri… | monomer | 1×1UH; | ||||
| Assess | ||||||
| Crystal structure of CPT1691 bound to TAK1-TAB1 | monomer | 1×6HF; | ||||
| Assess | ||||||
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 2 | monomer | 1×6V3; | ||||
| Assess | ||||||
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 10 | monomer | 1×6JV; | ||||
| Assess | ||||||
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 3 | monomer | 1×6V4; | ||||
| Assess | ||||||
| Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 12 | monomer | 1×6KD; | ||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8gw3.3.A | monomer | 0.78 | 92.72 | |||
| Assess | ||||||
| 7kja.1.A | monomer | 0.61 | 30.84 | |||
| Assess | ||||||
| 7kja.2.A | monomer | 0.61 | 30.84 | |||
| Assess | ||||||